Aclaris Announces Proposed Public Offering of Common Stock

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. SPY
9. SBUX
10. AXP

Go back to Aclaris Announces Proposed Public Offering of Common Stock

Aclaris Therapeutics (ACRS) Prices 4M Stock Offering at $22.75/Share

November 18, 2016 5:52 AM EST

Aclaris Therapeutics, Inc. (Nasdaq: ACRS) announced the pricing of its underwritten public offering of 4,000,000 shares of its common stock at a price to the public of $22.75 per share. The gross proceeds from the offering to Aclaris are expected to be $91.0 million. In addition, Aclaris has granted to the underwriters a 30-day option to purchase up to 600,000 additional shares of common stock at the public offering price, less the underwriting discount. The net proceeds from the offering to Aclaris are expected to be $85.2 million, after deducting underwriting discounts and commissions and estimated offering expenses, but... More